9H7U
Hexagonally ordered nanofibrils easily yield by dual amphiphilic self-assembling peptide
PDB DOI: 10.2210/pdb9h7u/pdb
Classification: PROTEIN FIBRIL Organism(s): N.A.
Deposited: 2024-10-28 Deposition Author(s): Baptista, L.A. , Gacanin, J. , Landfester, K. , Lieberwirth, I. , Mazzotta, F. , Schmidt, M. , Weil, T.
Experimental Data Snapshot
Method: ELECTRON MICROSCOPY Resolution: 2.96 Å
Hexagonally ordered nanofibrils easily yield by dual amphiphilic self-assembling peptide
Baptista, L.A. , Gacanin, J. , Landfester, K. , Lieberwirth, I. , Mazzotta, F. , Schmidt, M. , Weil, T.
Primary Citation of Related Structures: 9H7U
| Proteins | ||||
|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Sequence |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AA | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AB | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AC | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AD | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AE | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AF | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AG | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AH | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AI | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AJ | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AK | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AL | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AM | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AN | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AO | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AP | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AQ | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | AR | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CI | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CJ | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CK | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CL | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CM | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CN | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CO | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CP | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CQ | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CR | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CS | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CT | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CU | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CV | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CW | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CX | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CY | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | CZ | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | EQ | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | ER | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | ES | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | ET | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | EU | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | EV | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | EW | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | EX | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | EY | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | EZ | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FA | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FB | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FC | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FD | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FE | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FF | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FG | 9 | N.A. | KVKVSQINM |
| Peptide LYS-VAL-LYS-VAL-SER-GLN-ILE-ASN-MET | FH | 9 | N.A. | KVKVSQINM |
Experimental Data
Method: ELECTRON MICROSCOPY
Deposited Date: 2024-10-28 Deposition Author(s): Baptista, L.A. , Gacanin, J. , Landfester, K. , Lieberwirth, I. , Mazzotta, F. , Schmidt, M. , Weil, T.